Apply for the Merck Advance Biotech Grant Program
Your promising molecule requires resources and support to realize its potential. The Merck Advance Biotech Grant Program is open to European* biotech companies, to help you accelerate to the clinic faster. Apply before March 12, 2021 for a chance to win bioprocessing**/Actives and Formulation products and consultation.
The Winner will receive €255,000 to be used for the purchase of the following:
- 160,000€ in bioprocess technologies
- 40,000€ in bioprocess consulting services
- 40,000€ in Actives and Formulations catalogue portfolio for biomolecule formulation
- 15,000€ in a full subscription to Emprove® Suite for a one-year period
*Austria, Belgium, Denmark, France, Finland, Germany, Ireland, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, and United Kingdom. – see official rules for eligibility.
**Excludes BioReliance® Services